Table 1.
Patient | Age | Tumor size | Grade (NHG) | ER (%) | PR (%) |
---|---|---|---|---|---|
1 | 70 | 22 | 2 | >50 | >50 |
2 | 68 | 24 | 2 | >50 | >50 |
3 | 52 | 25 | 3 | >50 | 10–50 |
4 | 78 | 28 | 2 | >50 | >50 |
5 | 62 | 21 | 2 | >50 | >50 |
6 | 63 | 19 | 2 | >50 | >50 |
7 | 45 | 40 | 3 | 0 | 0 |
8 | 61 | 25 | 2 | >50 | >50 |
9 | 48 | 30 | 2 | >50 | >50 |
10 | 73 | 30 | 2 | >50 | <5 |
11 | 57 | 27 | 1 | >50 | >50 |
12 | 66 | 60 | 2 | >50 | >50 |
ER, estrogen receptor; PR, progesterone receptor; NHG, Nottingham histological grade.
All cancers were HER-2 negative.